PTPN14

protein-coding

protein tyrosine phosphatase non-receptor type 14, the group of FERM domain containing|Protein tyrosine phosphatases non-receptor type

Gene summary

The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. It appears to regulate lymphatic development in mammals, and a loss of function mutation has been found in a kindred with a lymphedema-choanal atresia. [provided by RefSeq, Sep 2010]

MANE transcript

NM_005401.5

Inheritance

AR

ClinVar variants

P:4U:167B:41

Top phenotype

Choanal atresia and lymphedema

gnomAD constraint

pLI —, LoF o/e 0.23

Max pathogenic AF

—

Genomic locus

chr1:214,348,700-214,552,449

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~203.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

lymphedema-posterior choanal atresia syndromeLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0013324

Submitter: Ambry Genetics

lymphedema-posterior choanal atresia syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013324

Submitter: Labcorp Genetics (formerly Invitae)

lymphedema-posterior choanal atresia syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013324

Submitter: G2P

lymphedema-posterior choanal atresia syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013324

Submitter: Orphanet

lymphedema-posterior choanal atresia syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013324

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Choanal atresia and lymphedemaAR

Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Craniofacial

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 7158640; 1872518; 20826270Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to PTPN14 variants in ClinVar

5 Conditions Cataloged
not specifiedTotal: 155
not providedTotal: 39
Lymphedema-posterior choanal atresia syndromeTotal: 24
PTPN14-related disorderTotal: 13
Esophageal atresia/tracheoesophageal fistulaTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005401.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
24
clinvar
5
clinvar
31
missense
1
clinvar
155
clinvar
9
clinvar
3
clinvar
168
nonsense
1
clinvar
3
clinvar
4
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
7
clinvar
8
Total31167338212

Highest pathogenic variant AF is 0.000008898588

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 16 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005401.5RefSeqNP_005392.218MANE Select
ENST00000366956.10EnsemblENSP00000355923.418MANE Select
ENST00000543945.5EnsemblENSP00000443330.16Standard
ENST00000543945.6EnsemblENSP00000443330.16Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • lymphangiogenesis
  • protein dephosphorylation
  • negative regulation of cell population proliferation
  • peptidyl-tyrosine dephosphorylation
  • regulation of protein export from nucleus

Molecular Function

  • transcription coregulator activity
  • protein tyrosine phosphatase activity
  • protein binding
  • receptor tyrosine kinase binding

Cellular Component

  • nucleus
  • nucleoplasm
  • cytoplasm
  • cytoskeleton

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000366956
Coding exons
18
Length
203754
Individuals with no LoFs
125725
Homozygous LoFs
0
Heterozygous LoFs
23
Defined
125748
p
0.0000915
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.685917180.8240.00004407814
Missense (PolyPhen)2022980.677853210
Synonymous-0.3952992901.030.00001972298
Loss of Function5.501459.90.2340.00000367623

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000190.00018rare
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish00.0absent
East Asian0.0000550.000054rare
Finnish0.000140.00014rare
European (Non-Finnish)0.0000880.000088rare
South Asian0.0000980.000098rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Protein tyrosine phosphatase which may play a role in the regulation of lymphangiogenesis, cell-cell adhesion, cell- matrix adhesion, cell migration, cell growth and also regulates TGF-beta gene expression, thereby modulating epithelial- mesenchymal transition. Mediates beta-catenin dephosphorylation at adhesion junctions. Acts as a negative regulator of the oncogenic property of YAP, a downstream target of the hippo pathway, in a cell density-dependent manner. May function as a tumor suppressor. {ECO:0000269|PubMed:10934049, ECO:0000269|PubMed:12808048, ECO:0000269|PubMed:17893246, ECO:0000269|PubMed:20826270, ECO:0000269|PubMed:22233626, ECO:0000269|PubMed:22525271, ECO:0000269|PubMed:22948661}.;
Disease
DISEASE: Choanal atresia and lymphedema (CATLPH) [MIM:613611]: A disease characterized by posterior choanal atresia and lymphedema. Additional features are a high-arched palate, hypoplastic nipples, and mild pectus excavatum. {ECO:0000269|PubMed:20826270}. Note=The disease is caused by mutations affecting the gene represented in this entry. A homozygous deletion in PTPN14 predicted to result in frameshift and premature truncation, has been shown to be the cause of choanal atresia and lymphedema in one family.; DISEASE: Note=Influence clinical severity of hereditary haemorragic telagiectasia (HHT). {ECO:0000269|PubMed:22233626}.;

Recessive Scores

pRec
0.283

Intolerance Scores

LoFtool
0.166
RVIS EVS
-0.3
RVIS percentile EVS
32.28

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.902

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.